JP2001039976A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001039976A5 JP2001039976A5 JP2000151138A JP2000151138A JP2001039976A5 JP 2001039976 A5 JP2001039976 A5 JP 2001039976A5 JP 2000151138 A JP2000151138 A JP 2000151138A JP 2000151138 A JP2000151138 A JP 2000151138A JP 2001039976 A5 JP2001039976 A5 JP 2001039976A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- active ingredient
- preventing
- agent
- prophylactic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000151138A JP2001039976A (ja) | 1999-05-24 | 2000-05-23 | 縮合複素環化合物の塩酸塩 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14351399 | 1999-05-24 | ||
| JP11-143513 | 1999-05-24 | ||
| JP2000151138A JP2001039976A (ja) | 1999-05-24 | 2000-05-23 | 縮合複素環化合物の塩酸塩 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001039976A JP2001039976A (ja) | 2001-02-13 |
| JP2001039976A5 true JP2001039976A5 (https=) | 2007-07-12 |
Family
ID=26475217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000151138A Ceased JP2001039976A (ja) | 1999-05-24 | 2000-05-23 | 縮合複素環化合物の塩酸塩 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001039976A (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7358255B2 (en) * | 2003-10-24 | 2008-04-15 | Santen Pharmaceutical Co., Ltd. | Therapeutic agent for keratoconjunctival disorder |
| CA2543555A1 (en) | 2003-10-29 | 2005-05-06 | Santen Pharmaceutical Co., Ltd. | Therapeutic agent for keratoconjunctival disorder |
| JP2006225382A (ja) * | 2005-01-24 | 2006-08-31 | Sankyo Co Ltd | チアゾリジンジオン化合物の製造方法及びその製造中間体 |
| TW200637856A (en) | 2005-01-24 | 2006-11-01 | Sankyo Co | Process for producing thiazolidinedion compound and intermediate thereof |
| JP5186217B2 (ja) | 2005-11-28 | 2013-04-17 | 千寿製薬株式会社 | Pparアゴニスト含有医薬 |
| JP2008044932A (ja) * | 2006-07-21 | 2008-02-28 | Daiichi Sankyo Co Ltd | チアゾリジンジオン化合物を含有する組成物 |
| TW200816995A (en) * | 2006-08-31 | 2008-04-16 | Daiichi Sankyo Co Ltd | Pharmaceutical composition containing insulin sensitizers |
| CA2687957C (en) | 2007-05-21 | 2014-11-25 | Senju Pharmaceutical Co., Ltd. | Pharmaceutical containing ppar.delta. agonist |
-
2000
- 2000-05-23 JP JP2000151138A patent/JP2001039976A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002244860B2 (en) | Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase IV | |
| JP2008007519A5 (https=) | ||
| RU2001131722A (ru) | 5-[4-(6-Метокси-1-метил-1Н-бензимидазол-2-илметокси)бензил]-тиазолидин-2,4 -ди он гидрохлорид, обладающий гипогликемической активностью | |
| JP2003501361A5 (https=) | ||
| AU2002244860A1 (en) | Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase IV | |
| TWI255817B (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof | |
| JP2010530431A5 (https=) | ||
| JP2006502187A5 (https=) | ||
| JP2007533722A5 (https=) | ||
| JP2007519649A5 (https=) | ||
| JP2004522714A5 (https=) | ||
| EP1806347A4 (en) | PYRIMIDINE DERIVATIVES FUSED WITH AN AROMATIC RING | |
| WO2009127974A3 (ko) | 심혈관계 질환 치료용 약제학적 제제 | |
| JP2005526696A5 (https=) | ||
| JP2004508399A5 (https=) | ||
| JP2001039976A5 (https=) | ||
| EP1612208A3 (en) | N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation | |
| US20160287549A1 (en) | Novel methods for treating neurodegenerative diseases | |
| JP2002508372A5 (https=) | ||
| WO2005039578A3 (en) | Use of a deoxynojirimycin derivative or a pharmaceutically salt thereof | |
| JP2002532416A5 (ja) | 脳のグルコース利用を増進させる医薬組成物 | |
| BR112019026029A2 (pt) | Formulações farmacêuticas orais de remogliflozina | |
| JP2002537246A5 (https=) | ||
| EP1541171A4 (en) | MEANS FOR THE TREATMENT OF DIABETES MELLITUS | |
| JPH09118624A5 (https=) |